Skip to main content
logo
Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.27
+0.01 (0.19%)
Aug 27, 2026, 12:39 PM EDT - Market open

Orchestra BioMed Holdings Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
31.9833.482.642.763.53-0.78
Revenue Growth
986.14%1169.22%-4.42%-21.88%--
Gross Profit
31.8233.292.432.573.32-0.98
Operating Income
-57.99-51.81-64.3-51.51-32.66-21.8
Net Income
-59.57-52.96-61.02-49.12-33.61-23.01
Earnings Per Share
-1.00-1.11-1.66-1.48-2.24-10.90
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
109.96106.5166.8187.683.7910.9
Total Debt
70.7632.4416.531.6911.875.67
Net Cash (Debt)
39.274.0850.2885.9171.925.22
Net Cash Growth
123.13%47.32%-41.47%19.46%1276.89%-80.17%
Net Cash Per Share
0.661.551.372.594.802.47

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-58.32-48.96-50.56-46.13-29.29-19.43
Capital Expenditures
-0.78-0.49-0.29-0.08-0.59-0.27
Free Cash Flow
-59.1-49.45-50.85-46.21-29.88-19.7
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
99.51%99.43%92.27%93.26%94.03%-
Operating Margin
-181.36%-154.73%-2437.49%-1866.16%-924.34%-
Pretax Margin
-184.60%-157.40%-2313.27%-1779.71%-951.26%2942.97%
Profit Margin
-186.30%-158.16%-2313.27%-1779.71%-951.26%-
FCF Margin
-184.83%-147.70%-1927.48%-1674.09%-845.74%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
9.897.0057.64118.2431.67-263.60